.2018 .Frequency of ischemic stroke subtypes based on toast classification at a tertiary care center in Pakistan. Asian J Neurosurgery, 13(4) : 984-9.
Rashid MH,Yaseen G,Ghaffar U,Khan AA,Kabir A,Aisha A .2020 .Prevalence of Acute Coronary Syndrome and Various Risk Factors in Acute Stroke Patients. Cureus, 12(8) : e9552.
Ahmed I,Nasir A,Shams P,Shahab H,Hassan M,Subhani F .2022 .Clinical characteristics and prognostic factors of atrial fibrillation at a tertiary center of Pakistan-From a South-Asian perspective-A cross-sectional study. Annals Med Surg, 73 : 103128.
Windecker S,Lopes RD,Massaro T,Jones-Burton C,Granger CB,Aronson R .2019 .Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated medically or with percutaneous coronary intervention or undergoing elective percutaneous coronary intervention: insights from the AUGUSTUS trial. Circulation, 140(23) : 1921-32.
Suo N,Yang YM,Wang J,Zhang H,Shao XH,Wu S .2022 .Evolving antithrombotic treatment patterns for patients with nonvalvular atrial fibrillation and acute coronary syndrome or underwent percutaneous coronary intervention in China: a crosssectional study. Frontiers Cardiovasc Med, 9 : 846803.
Camm A J,Accetta G,Ambrosio G,Atar D,Bassand JP,Berge E .2017 .Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation. Heart, 103(4) : 307-14.
Potpara TS,Lip GY,Dagres N,Crijns HJ,Boriani G,Kirchhof P .2021 .Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry. Heart Journal - Qual Care Clin Outcomes, 7(3) : 229-37.
Wolfes J,Ellermann C,Frommeyer G .2022 .CCS guidelines on the management of atrial fibrillation. Reviews Cardiovasc Med, 23(2) : 56.
Jr Smith,Feldman SC,Hirshfeld Jr TE,Jacobs JW,Kern AK,King MJ,III SB MJ .2006 .update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous. J Am Coll Cardiol, 47(1) : e1-121.
Hindricks G,Potpara T,Dagres N,Arbelo E,Bax JJ,BlomströmLundqvist C .2021 .ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European. Eur Heart J, 42(5) : 373-498.
Moustafa A,Khan M,Saud M,Abdalla AM,Amer B,Muhammad S. Safety .2020 .and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis. Avicenna J Med, 10(4) : 232-40.
van Rein N,Heide-Jørgensen U,Lijfering WM,Dekkers OM,Sørensen HT,Cannegieter SC .2019 .Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy: results from a Nationwide Danish Cohort Study. Circulation, 139(6) : 775-86.
Leon MB,Baim DS,Popma JJ,Gordon PC,Cutlip DE,Ho KK .1998 .A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. New Eng J Med, 339(23) : 1665-71.
Connolly S,Pogue J,Hart R,Pfeffer M,Hohnloser S,Chrolavicius S .2006 .Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet, 367(9526) : 1903-12.
Luo CF,Mo P,Li GQ,Liu SM .2021 .Aspirin-omitted dual antithrombotic therapy in non-valvular atrial fibrillation patients presenting with acute coronary syndrome or undergoing percutaneous coronary intervention: results of a meta-analysis. European Heart Journal - Cardiovasc Pharmacother, 7(3) : 218-24.
Dharma S. Double .2020 .Antithrombotic versus Triple Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome. Inter J Angiol, 29(02) : 081-087.
Dewilde WJ,Oirbans T,Verheugt FW,Kelder JC,De Smet BJ,Herrman JP .2013 .Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet, 381(9872) : 1107-15.
Golwala H,Jackson II L R DN,Piccini JP,Gersh B,Go AS .2016 .Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Am Heart J, 174 : 29-36.
Li L,Geraghty OC,Mehta Z,Rothwell PM .2017 .Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet, 390(10093) : 490-9.
Mentias A,Briasoulis A,Shantha G,Alvarez P,Vaughan-Sarrazin M .2019 .Impact of heart failure type on thromboembolic and bleeding risk in patients with atrial fibrillation on oral anticoagulation. Am J Cardiol, 123(10) : 1649-53.
Diabetes Reports Current .2012 .. , 13 : 294-304.
.2013 .Diabetes is an independent risk factor for peptic ulcer bleeding: A nationwide population?based cohort study. J Gastroenterol Hepatol, 28(8) : 1295-9.
Moisi MI,Rus M,Bungau S,Zaha DC,Uivarosan D,Fratila O .2020 .Acute coronary syndromes in chronic kidney disease: clinical and therapeutic characteristics. Medicina, 56(3) : 118.
Burlacu A,Genovesi S,Goldsmith D,Rossignol P,Ortiz A,Kalra PA .2018 .Bleeding in advanced CKD patients on antithrombotic medication-a critical appraisal. Pharmacol Res, 129 : 535-43.